Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from the growing demand for lab space.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong pipeline of opportunities.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, focusing on life sciences properties that can benefit from strategic repositioning.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator at the GP level, focusing on those with a strong track record in managing vacancies.

Co-GP / Platform:A family office could deploy into the Washington, D.C. life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of emerging opportunities.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator focused on innovative medical technologies to share in the promote.

Co-GP / Platform:A family office could deploy into the Washington, D.C. life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator focused on biotech developments, sharing in the promote and benefiting from the growth of the sector.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of development projects.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong pipeline of projects.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong pipeline of developments.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of development projects.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator focused on life sciences developments, sharing in the promote and benefiting from a repeatable pipeline of projects.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from a strong deal pipeline.

Co-GP / Platform:A family office could deploy into the Washington D.C. life sciences market by backing a sponsor or operator at the GP level to share in the promote and access a pipeline of investment opportunities.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor or operator at the GP level, sharing in the promote and benefiting from the sector's growth.

Co-GP / Platform:A family office could deploy into the Washington D.C. life sciences market by backing a sponsor or operator at the GP level to capitalize on the growing investment activity.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, capitalizing on the region's strong VC funding and development activity.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator involved in the development of new facilities or funding innovative biotech companies.